Literature DB >> 15896501

Burn scar neoplasms: a literature review and statistical analysis.

Areta Kowal-Vern1, Bryan K Criswell.   

Abstract

BACKGROUND: Although squamous cell carcinoma (SCC) is the most common burn scar neoplasm, other neoplasms have also been reported.
OBJECTIVE: To compile the burn scar neoplasm cases in the literature and to analyze their frequency and demographic characteristics.
MATERIALS AND METHODS: Cases were obtained through literature searches.
RESULTS: There were 412 cases gleaned from 146 articles between 1923 and 2004. Seventy-one percent (293) of the tumors were squamous cell carcinoma, 12% (48) were basal cell carcinoma (BCC), 6% (23) were melanoma, 5% (21) were sarcoma, 4% (16) were other neoplasms, 1% (6) were squamo-basal cell carcinoma, and 1% (5) squamous cell-melanoma. The mean age at tumor diagnosis was 50 years, the mean age at the time of burn injury was 20 years, the mean latency interval was 31 years. Only 5% of the reported cases were excised and grafted at the time of injury (p<0.001). BCC occurred at a significantly later age compared to SCC and sarcoma groups (p<0.02) and had a shorter latency period compared to SCC and sarcoma groups (p<0.004) and melanoma (p<0.008). Local recurrence was present in 16% of the cases, while regional lymph node involvement was seen in 22% of the cases and distant metastases was present in 14% of the patients. The mortality rate was 21%.
CONCLUSIONS: Although the main burn scar neoplasm was SCC, other neoplasms contributed to the morbidity and mortality of burn patients. Excision and grafting of deep burns, and close follow-up of non-healing ulcerated burn scars is essential for the prevention and early detection of burn scar neoplasms.

Entities:  

Mesh:

Year:  2005        PMID: 15896501     DOI: 10.1016/j.burns.2005.02.015

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  46 in total

Review 1.  Marjolin's ulcers in sub-Saharan Africa.

Authors:  Peter M Nthumba
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

2.  Marjolin's squamous cell carcinoma of the hallux following recurrent ingrown toenail infections.

Authors:  Wahid Abdul; Barry James O'Neill; Anthony Perera
Journal:  BMJ Case Rep       Date:  2017-06-14

3.  Clinicopathologic Characteristics and Prognosis Analysis of Marjolin's Ulcer in 40 Cases.

Authors:  Bi-Wei Guo; Teng Pan; Hong-Bo Chen; Li Zhu; Meng Tian; Jie-Cong Wang; Xiao-Dan Li
Journal:  Curr Med Sci       Date:  2018-12-07

Review 4.  Marjolin's ulcer: a rare entity with a call for early diagnosis.

Authors:  Fahad Mujtaba Iqbal; Yashashwi Sinha; Wayne Jaffe
Journal:  BMJ Case Rep       Date:  2015-07-15

5.  Dermatofibrosarcoma protuberans arising from a burn scar.

Authors:  Jong Keun Seo; Kyung Jong Cho; Ju Hyun Kang; Deborah Lee; Ho-Suk Sung; Seon Wook Hwang
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

6.  [Parallels between wound healing, chronic inflammatory skin diseases and neoplasia: clinical aspects].

Authors:  A Brown; I Tantcheva-Poor; S A Eming
Journal:  Hautarzt       Date:  2014-11       Impact factor: 0.751

7.  A review of 31 cases of Marjolin's ulcer on scalp: Is it necessary to preventively remove the scar?

Authors:  Haitao Xiao; Ke Deng; Ruolin Liu; Zihang Chen; Yun Lin; Yuan Gao; Ying Cen; Xuewen Xu
Journal:  Int Wound J       Date:  2018-12-26       Impact factor: 3.315

8.  Marjolin's Ulcer in a Post Burn Scar of the Hand.

Authors:  Selvan Ranganathan; Surya Rao Rao Venkata Mahipathy; Sridharan Murugesan
Journal:  J Clin Diagn Res       Date:  2015-08-01

9.  Epithelioid sarcoma and squamous cell carcinoma arising in a burn scar.

Authors:  Kusum D Jashnani; Varsha M Dhume; Naresh K Bahal
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

10.  TGFβ, Fibronectin and Integrin α5β1 Promote Invasion in Basal Cell Carcinoma.

Authors:  François Kuonen; Isabelle Surbeck; Kavita Y Sarin; Monique Dontenwill; Curzio Rüegg; Michel Gilliet; Anthony E Oro; Olivier Gaide
Journal:  J Invest Dermatol       Date:  2018-07-14       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.